Omeros (OMER) Announces FDA Grants Orphan Drug Designation for OMS721 for Treatment of IgA Nephropathy

August 4, 2017 11:10 AM

Omeros Corporation (NASDAQ: OMER) today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found